These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8067703)
1. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Heiny BM; Beuth J Anticancer Res; 1994; 14(3B):1339-42. PubMed ID: 8067703 [TBL] [Abstract][Full Text] [Related]
2. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Heiny BM; Albrecht V; Beuth J Anticancer Res; 1998; 18(1B):583-6. PubMed ID: 9568181 [TBL] [Abstract][Full Text] [Related]
3. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients]. Beuth J; Stoffel B; Ko HL; Buss G; Tunggal L; Pulverer G Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151 [TBL] [Abstract][Full Text] [Related]
4. [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract]. Beuth J; Ko HL; Tunggal L; Geisel J; Pulverer G Arzneimittelforschung; 1993 Feb; 43(2):166-9. PubMed ID: 7681287 [TBL] [Abstract][Full Text] [Related]
5. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1. Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981 [TBL] [Abstract][Full Text] [Related]
6. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice. Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751 [TBL] [Abstract][Full Text] [Related]
7. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract. Beuth J; Stoffel B; Ko HL; Jeljaszewicz J; Pulverer G Arzneimittelforschung; 1995 Nov; 45(11):1240-2. PubMed ID: 8929248 [TBL] [Abstract][Full Text] [Related]
8. [Immunoactive action of mistletoe lectin-1 in relation to dose]. Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice. Stoffel B; Krämer K; Mayer H; Beuth J Anticancer Res; 1997; 17(3C):1893-6. PubMed ID: 9216641 [TBL] [Abstract][Full Text] [Related]
10. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830 [TBL] [Abstract][Full Text] [Related]
11. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. Beuth J; Ko HL; Gabius HJ; Pulverer G In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621 [TBL] [Abstract][Full Text] [Related]
12. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. Bocci V J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712 [TBL] [Abstract][Full Text] [Related]
13. Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks. Dohmen W; Breier M; Mengs U Anticancer Res; 2004; 24(2C):1231-7. PubMed ID: 15154652 [TBL] [Abstract][Full Text] [Related]
14. Mistletoe lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production. Boneberg EM; Hartung T J Pharmacol Exp Ther; 2001 Sep; 298(3):996-1000. PubMed ID: 11504795 [TBL] [Abstract][Full Text] [Related]
15. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe? Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410 [TBL] [Abstract][Full Text] [Related]
16. [Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients]. Beuth J; Gabius HJ; Steuer MK; Geisel J; Steuer M; Ko HL; Pulverer G Med Klin (Munich); 1993 May; 88(5):287-90. PubMed ID: 7687001 [TBL] [Abstract][Full Text] [Related]
17. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes. Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281 [TBL] [Abstract][Full Text] [Related]
18. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567 [TBL] [Abstract][Full Text] [Related]
19. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects. Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Klein R J Soc Integr Oncol; 2006; 4(1):3-7. PubMed ID: 16737665 [TBL] [Abstract][Full Text] [Related]
20. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Hajto T; Hostanska K; Gabius HJ Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]